AstraZeneca Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | AstraZeneca PLC

AstraZeneca PLC | Ownership

Companies that own AstraZeneca PLC

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

BlackRock Investment Management (UK) Ltd.

51,441,535

4.05%

5,369,730

1.07%

12/31/2017

Capital Research & Management Co. (World Investors)

45,026,061

3.55%

6,427,427

0.48%

07/16/2018

Legal & General Investment Management Ltd.

27,742,000

2.19%

791,000

0.96%

08/01/2018

The Vanguard Group, Inc.

27,575,913

2.18%

-4,964,434

0.07%

08/01/2018

Norges Bank Investment Management

26,624,000

2.1%

202,000

0.28%

08/01/2018

Dodge & Cox

20,317,000

1.6%

0.8%

08/01/2018

Fidelity Management & Research Co.

17,044,000

1.35%

194,000

0.13%

08/01/2018

SSgA Funds Management, Inc.

13,409,691

1.06%

247,589

0.08%

08/01/2018

Threadneedle Asset Management Ltd.

13,370,869

1.06%

-335,278

1.55%

08/01/2018

Franklin Advisers, Inc.

13,350,000

1.05%

0.67%

08/01/2018

About AstraZeneca

View Profile

Address	Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AA United Kingdom
Employees	-
Website	http://astrazeneca.com
Updated	07/08/2019
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 0382, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta.